Work

670P Preliminary efficacy and safety of tinengotinib (TT-00420) monotherapy in Chinese patients (pts) with advanced solid tumors: Results from a phase Ib/II study

Year: 2023

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.1856

Authors: P. Zhang, J. Gong, H. Guo, W. Han, B. Cao, J. Zhang, Z. Niu, Y. Cheng, C. He, J. Fan, P. Peng, C. Sun, H. Wang, Y. Yu, Y. Zhu, Y. Wu, Q. Li, P. Huang, F. Wu, L. Shen

Institutions: Peking University Cancer Hospital, Nanjing Drum Tower Hospital, Hunan Cancer Hospital, Peking University Third Hospital, Fudan University, Fudan University Shanghai Cancer Center, Shandong University, Shandong Tumor Hospital, Jilin Province Tumor Hospital, Henan Cancer Hospital

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387811521

FWCI: 0.199

Cites:

Cited by: 1

Related to: 10